Sontra Medical gears up for the fast lane with SonoPrep
This article was originally published in Clinica
Executive Summary
Nasdaq-listed transdermal diagnosis and delivery company Sontra Medical is making the transition from R&D start-up to manufacturing company, CFO Sean Moran explained to Ashley Yeo during a brief break from a tour of prospective international investors.